Advanced Medical Isotope Corporation (OTC:ADMD)
719 Jadwin Avenue. Richland, Washington 99352 US
T: 509.736.4000 E:


Latest News

Click here for more news and updates

Twitter • Industry News

Advisory Boards.

Dr. Barry D. Pressman MD, FACR - Chairman Medical Advisory Board

Dr. Barry D. Pressman MD, FACR
Dr. Barry D. Pressman MD, FACR

Dr. Pressman is Professor and Chairman of the S. Mark Taper Foundation Imaging Center and Department, and Chief of the Section of Neuroradiology and Head and Neck Radiology at Cedars-Sinai Medical Center, located in Los Angeles, Ca.


Dr. Pressman is a past President of The American College of Radiology, the Western Neuroradiological Society, as well as past President of the California Radiological Society. Currently he is a member of the American Society of Neuroradiology and the American Society of Pediatric Neuroradiology.


Dr. Pressman earned his medical degree Cum Laude from Harvard Medical School after graduating Summa Cum Laude from Dartmouth College. After a surgical internship at Harvard's Peter Bent Brigham Hospital in Boston, he completed a diagnostic radiology residency at Columbia-Presbyterian Medical Center in New York and a Neuroradiology fellowship at George Washington University Hospital. During this period, he wrote many original papers for Computer Tomography(CT).


"I am delighted to be appointed to Chair the newly formed Medical Advisory Board (MAB) for ADMD. I anticipate rapid expansion of our MAB, initially focusing on the potential for the Company's brachytherapy products," said Pressman.

I am delighted to be appointed to Chair the newly formed Medical Advisory Board (MAB) for ADMD. I anticipate rapid expansion of our MAB, initially focusing on the potential for the Company's brachytherapy products

– Dr. Barry Pressman MD, FACR

Dr. Alice Villalobos, DVM, FNAP  - Chairwoman of the Veterinary Medicine Advisory Board

Dr. Alice Villalobos (and Neo)
Dr. Alice Villalobos (and Neo)

Dr. Alice Villalobos is a well known pioneer in the field of cancer care for companion animals and a founding member of the Veterinary Cancer Society. A 1972 graduate of UC Davis, she completed Dr. Gordon Theilen’s first mock residency program in oncology and has served the profession by consulting, writing and lecturing in the rapidly growing field of veterinary oncology and end of life care.


Dr. Alice Villalobos is President Emeritus of the Society for Veterinary Medical Ethics, Past President of the American Association of Human Animal Bond Veterinarians and Chair of the Veterinary Academy for the National Academies of Practice. She operated Coast Pet Clinic/Animal Cancer Center for 25 years, which is now VCA Coast Animal Hospital. She is the author of numerous articles, papers, and including her classic veterinarian textbook, Canine and Feline Geriatric Oncology: Honoring the Human-Animal Bond. She has lectured worldwide on oncology, quality of life, the human-animal bond and end of life care and bioethics. She founded Pawspice, an end of life care program that embraces kinder, gentler palliative cancer medicine and integrative care for pets with cancer and terminal illness ( Dr. Alice is Director of Animal Oncology Consultation Service in Woodland Hill, California and Pawspice at VCA Coast Animal Hospital in Hermosa Beach, California. Dr. Alice was elected 2016 Hermosa Beach Woman of the Year.


Dr. Alice’s role with ADMD is to support the commercialization of the Company’s yttrium-90 brachytherapy products for use in companion animals.

Dr. Albert S. DeNittis MD, MS, FCPP - Medical Advisory Board.

Dr. Albert S. DeNittis MD
Dr. Albert S. DeNittis MD

Dr. Albert S. DeNittis is currently is the Chief of Radiation Oncology at Lankenau Medical Center and Clinical Professor at Lankenau Insitute for Medical Research in Wynnewood, Pennsylvania and the Director of Radiation Oncology at Brodesseur Cancer Center in New Jersey. He is also the Principal Investigator and in charge of a grant awarded by the NIH for its National Cancer Oncology Research Program (NCORP) at Main Line Health. Dr. DeNittis practice experience includes image-guided radiosurgery, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), high-dose rate (HDR) brachytherapy, cranial and extracranial stereotactic radiosurgery, respiratory gating, and Cyberknife.
Dr. DeNittis has served on numerous regional, national and government committees related to key issues in the field of oncology including the NRG Oncology group which focuses on protocol development for cancer patients on the national level. He has received regional and national awards for his research and his clinical work and authored over 100 publications and presentations as well as 6 book chapters. He has. Dr. DeNittis previously has been awarded a number of grants to study the impact of various novel oncology drugs and radiation protocols. He is a long standing member of key professional societies including the American Society of Radiation Oncology, the American Society of Clinical Oncology, and American Brachytherapy Society. Dr. DeNittis is a cofounder and board member of DermRad Therapy which is developing a multidisciplinary approach to skin cancer treatment.
Dr. DeNittis earned a BA and a MS at Rutgers University and a MD from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey. He completed postdoctoral training internships and residency at the Department of Radiation Oncology at the Hospital of the University of Pennsylvania. Dr. DeNittis is board certified by the American Board of Radiology and Licensed in New Jersey and Pennsylvania.

Dr. Howard M. Sandler, MD, MS, FASTRO, FASCO - Medical Advisory Board.

Dr. Howard M. Sandler
Dr. Howard M. Sandler

Dr. Sandler is Ronald H. Bloom Family Chair in Cancer Therapeutics and Professor and Chairman of Radiation Oncology and a member of the Samuel Oschin Cancer Institute, Cedars-Sinai Medical Center, Los Angeles.  He received his undergraduate degree, masters in physics and medical degree from the University of Connecticut and completed his training in Radiation Oncology at the University of Pennsylvania.  He was recruited to Cedars-Sinai in 2008 from the University of Michigan, where he served as Newman Family Professor of Radiation Oncology. Dr. Sandler’s research interests include prostate and other genitourinary tumors, as well as a broad range of subjects related to radiation oncology. He has served as chairman of the Radiation Therapy Oncology Group -- now part of NRG Oncology -- Genitourinary Cancer Committee since 1997. He has written nearly 300 peer-reviewed publications primarily on prostate cancer and radiation therapy.

Dr. Beau Bosko Toskich MD,  - Medical Advisory Board.

Dr. Beau Bosko Toskich MD
Dr. Beau Bosko Toskich MD

Dr. Toskich is a Senior Associate Consultant in Vascular and Interventional Radiology at Mayo Clinic’s Florida Campus and Assistant Professor, Vascular and Interventional Radiology, at the University of Florida College of Medicine. He earned his M.D. from Florida State University College of Medicine and completed a fellowship in Vascular and Interventional Radiology at the University of Florida. He is Board Certified in Diagnostic Radiology, Vascular and Interventional Radiology, and a Nuclear Regulatory Commission Authorized User.